A Phase II study of CS1 in patients undergoing orthopedic surgery
Latest Information Update: 01 Apr 2020
At a glance
- Drugs Valproic acid (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
Most Recent Events
- 30 Mar 2020 According to a Cereno Scientific media release, due to the global spread of the Sars-cov-2 virus, the company will postpone this planned trial. The start of the study was previously planned for mid-year 2020. Cereno Scientific is adjusting planned activities to start by the end of the year, but is prepared for further adjustments if needed, due to the uncertainty of the further development of the pandemic.
- 27 Feb 2020 According to a Cereno Scientific media release, the company expects to initiate this trial in mid-year 2020.
- 27 Feb 2020 According to a Cereno Scientific media release, the authorities in Bulgaria have issued approval regarding the company's application to initiate this trial on 19th November 2019.